What’s New

News

May 10, 2024

Alimentiv: A Global GI-Focused CRO with end-to-end clinical trial services and imaging solutions leading with innovation at DDW 2024

London, Ontario, Canada, May 13, 2024 – Alimentiv Inc. (“Alimentiv”) is pleased to announce two lecture presentations and six poster presentations at the Digestive Disease Week (DDW) Meeting…

Article

Mar 19, 2024

Countdown to Discovery: Previewing the Upcoming GI Clinical Trial Conferences In 2024

Explore GI clinical trial conferences in 2024 with our curated roster of events. This chronological listing offers an overview of the most influential gatherings worldwide, providing unparalleled oppo…

Article

Aug 2, 2023

Samples, Assays, and Analyses: Building a Biomarker Plan for Precision Medicine in Clinical Trials

Designing a biomarker plan for a clinical trial can be challenging due to the plethora of assays and advancing technologies that are now readily available. A well-defined biomarker plan sets the stage…

News

Jun 26, 2023

Alimentiv Inc. launches Alimentiv Statistics

London, Ontario, Canada, June 27, 2023, Alimentiv Inc. (“Alimentiv”) today announced the launch of Alimentiv Statistics, a core Alimentiv product line focused on being the recognized leader for st…

Publication

Jun 15, 2023

Efficacy and Safety of IL-12/23 and IL-23 Inhibitors for Crohn’s Disease: Systematic Review and Meta-Analysis

Brian G Feagan, Christopher Ma, Claire E Parker, Vipul Jairath.

Publication

Jun 15, 2023

Efficacy and safety of advanced oral small molecules for inflammatory bowel disease: Systematic review and meta-analysis

Brian G Feagan, Christopher Ma, Claire E Parker, Vipul Jairath.

Publication

Jun 2, 2023

Targeting IL-23 for IBD: Rationale and Progress to Date

Brian G Feagan, Christopher Ma, Vipul Jairath.

Publication

May 29, 2023

Effect of storage time on peripheral blood mononuclear cell isolation from blood collected in vacutainer CPT™ tubes

Niels Vande Casteele, Vipul Jairath, Wendy Teft.